New study finds weight loss jabs not only help tackle obesity but may significantly reduce alcohol use, offering wide health ...

Hims & Hers rebounds with key partnerships and launches, achieving 111% YoY revenue growth. Learn more about HIMS stock here.

DRL's management has guided for double-digit growth in FY26, with margins expected to remain similar to FY25 levels. Here's ...

A MUM has shared a downside of her epic weight loss transformation after being on Mounjaro for over two months. Scottish mum Kirsty took to TikTok after she shed almost a staggering 5 stone while ...

The celebrated actress has lost more than 100Ib after turning to controversial diabetes jab Ozempic - now better known for its impact on tackling obesity ...

Scientists are continuing to find evidence that GLP-1 medications can temper cravings for alcohol and other drugs.

Individuals who take liraglutide or semaglutide for weight loss reduce their alcohol consumption by almost two-thirds in four ...

After nearly 18 years on medication to manage her high blood pressure, Charity Wischmeyer, 51, is now discussing with her ...

Naim Alkhouri, MD, spoke to the potential for glucagon-like peptide-1 (GLP-1) receptor agonists to transform the treatment ...

Findings showed a 13.6% reduction in body weight in the semaglutide 25mg group compared with a 2.2% reduction in the placebo group.

Q2 2025 Results Conference Call May 8, 2025 8:00 AM ETCompany ParticipantsSam Fisch - Executive Director, Investor Relations ...

The company’s blockbuster drugs helped it beat Wall Street’s expectations—while WeightWatchers declares bankruptcy. One day ...